QualityStocksNewsBreaks Archives - Page 449 of 1421

FridayApr 08, 2022 1:06 pm

QualityStocksNewsBreaks – Mydecine Innovations Group Inc. (NEO: MYCO) (OTC: MYCOF) Working to Capitalize on Psychedelics Therapeutics Market’s Growth

Mydecine Innovations (NEO: MYCO) (OTC: MYCOF) is a biotechnology and digital technology company aiming to transform the treatment of mental health and addiction disorders. A recent article discusses the company’s efforts to lead the charge toward developing novel psychedelic and non-psychedelic molecules for medical use. “Its research and development efforts have focused on compounds that can enable safer and more effective treatments for patients dealing with mental health and addiction disorders with unmet needs,” the article reads. “Mydecine, through its research, has positioned itself to capitalize on the opportunities in the industry, particularly with regards to psychedelic medicine for the treatment…

FridayApr 08, 2022 12:15 pm

QualityStocksNewsBreaks – LQwD FinTech Corp.’s (TSX.V: LQWD) (OTCQB: LQWDF) PaaS Platform Facilitating Instant, Secure, Inexpensive Payments

LQwD FinTech (TSX.V: LQWD) (OTCQB: LQWDF), a company focused on developing institution-grade payment infrastructure, liquidity and solutions for the Lightning Network, introduced its platform-as-a-service (“PaaS”) in November 2021. The platform offers users the ability to make payments instantly, securely and inexpensively while leveraging the Lightning Network. “Since that time, LQwD has also invested in the Lightning Network, with nine active public nodes. The active nodes include France, England, Singapore, Sweden, Italy, Indonesia, Germany, Ireland, and the U.S. Collectively, the public nodes have a value of 10.21604901 BTC ($429,153.33) and 183 active channels,” a recent article reads. This comes amid growth…

FridayApr 08, 2022 11:36 am

QualityStocksNewsBreaks – Cybin Inc. (NYSE American: CYBN) (NEO: CYBN) Further Strengthens Long-Term IP Position of Psychedelic-Based Programs

Cybin (NYSE American: CYBN) (NEO: CYBN), a biopharmaceutical company focused on progressing “Psychedelics to Therapeutics(TM),” has announced that the World Intellectual Property Organization (“WIPO”) published an international patent application covering a range of inhalation delivery methods across multiple psychedelic molecules (Patent Cooperation Treaty (‘PCT’) patent application no.PCT/EP2021/077057). This further strengthens the company’s long-term intellectual property (“IP”) position of psychedelic-based programs. “The publication of this PCT patent application demonstrates our continued commitment to discovering and developing new psychedelic-based treatment options, in addition to identifying and combining potentially improved and well-controlled delivery systems with these clinical candidates,” said Cybin CEO Doug Drysdale.…

ThursdayApr 07, 2022 2:34 pm

QualityStocksNewsBreaks – Nowigence Inc.’s Pluaris Helping Users Make Sense of Massive Amounts of Textual Data

Nowigence has introduced Pluaris, an all-in-one, easy-to-use personal knowledge management platform designed to assist users with automated reading and analysis of textual data. “The system reads and analyzes articles, documents and other textual data, enabling readers to learn more in less time, uncover hidden insights, and stay on top of the information they need to know. Pluaris helps individuals, teams and entire enterprises make sense of massive amounts of textual data, converting them into bite-size nuggets of intelligence in a short span of time,” a recent article explains. “Once Pluaris has done its job, users simply scan their customized newsfeeds…

ThursdayApr 07, 2022 2:18 pm

QualityStocksNewsBreaks – Why Silo Pharma Inc. (SILO) Is ‘One to Watch’

Silo Pharma (OTCQB: SILO) is committed to developing innovative solutions to address various underserved conditions such as post-traumatic stress disorder (“PTSD”), fibromyalgia, Alzheimer’s, Parkinson’s, and other rare neurological disorders as part of its focus on merging traditional therapeutics with psychedelic research. “Silo works to identify and partner with leading medical universities, providing the needed financial resources to develop safe therapeutic treatments while moving cutting-edge research through the clinical stage and into commercialization. The company is well-capitalized with access to additional funds as opportunities present themselves,” a recent article reads. Silo Pharma is involved in a sponsored study with Maastricht University…

ThursdayApr 07, 2022 1:30 pm

QualityStocksNewsBreaks – FuelPositive Corporation (TSX.V: NHHH) (OTCQB: NHHHF) Adds Talent to Capitalize on Broad Range of Emerging Agricultural Opportunities

FuelPositive (TSX.V: NHHH) (OTCQB: NHHHF) recently announced that experienced global agricultural product operations leader Derek Boudreau joined the company as a strategic advisor, responsible for agricultural implementation. Boudreau joins FuelPositive after more than 27 years with John Deere Company. His addition to the team highlights the company’s build-up toward commercialization of its intellectual property (“IP”), with FuelPositive expecting to begin rolling out the prototype of its modular green ammonia production systems in late summer 2022. A recent article quotes FuelPositive CEO and Board Chair Ian Clifford as saying: “[Boudreau’s] vast experience working in sales, management, manufacturing, and distribution with agricultural…

ThursdayApr 07, 2022 12:53 pm

QualityStocksNewsBreaks – Kronos Advanced Technologies Inc. (KNOS) Developing the Most Effective Clean-Air Solution on the Market

Kronos Advanced Technologies (OTC: KNOS), a revenue-generating product development and production company that has significantly changed the way air is moved, filtered and disinfected, has developed one of the most effective air purifiers available today. With reports showing that indoor air pollution is a risk factor for several of the world’s leading causes of death, including heart disease, pneumonia, stroke, diabetes, lung cancer, and viruses, air purifiers can help remove or reduce pollutants by using a combination of chemicals, physical filters and devices. A recent article reads: “Kronos is making its presence felt in the growing sector with its proprietary,…

ThursdayApr 07, 2022 12:29 pm

QualityStocksNewsBreaks – SPYR Inc.’s (SPYR) Applied Magix Plans New Digital Marketing Campaign

SPYR (OTCQB: SPYR), dba SPYR Technologies, a technology company and its subsidiary, Applied Magix Inc., is planning to expand its online marketing efforts. Applied Magix is focused on developing and reselling Apple(R) ecosystem-compatible products in the multibillion-dollar smart home and connected car markets, which are seeing significant growth. The company initially focused on TV marketing, it is now turning attention to its next marketing phase, which includes the digital marketplace. “We are planning to expand our marketing footprint in a more customer-focused manner to the online market space,” said Applied Magix CEO Dr. Harald Zink in the press release. “We already…

ThursdayApr 07, 2022 12:17 pm

QualityStocksNewsBreaks – Knightscope Inc. (NASDAQ: KSCP) Deploys Proprietary ASR in North Carolina

Knightscope (NASDAQ: KSCP), a developer of advanced physical security technologies focused on enhancing U.S. security operations, continues to expand its footprint with its latest Knightscope K5 Autonomous Security Robot (“ASR”) contract. The company announced that it has deployed an ASR with a Fortune 500 company located in Charlotte, North Carolina. According to the announcement, the K5 ASR was added to an “already robust security program to help provide an even safer environment for its customers and employees.” The announcement also noted that Charlotte’s property crime rate is higher than average. Ranked on a scale of 1 to 100, the city…

ThursdayApr 07, 2022 12:12 pm

QualityStocksNewsBreaks – SRAX Inc. (NASDAQ: SRAX) Announces Upcoming Cannabis & Psychedelic Conference

SRAX (NASDAQ: SRAX), a financial technology company that unlocks data and insights for publicly traded companies through Sequire, its SaaS (“SaaS”) platform, has announced that the Sequire Cannabis & Psychedelic Conference is scheduled for April 20, 2022, from 9 a.m. to 4 p.m. ET. The conference will be held via SRAX’s Sequire Virtual Events. The one-day virtual event is expected to draw significant numbers; almost 9 million active small cap investors have been invited to attend. The event agenda keynote addresses by several well-known names in the industry and also includes some 25 cannabis and psychedelic companies offering 25-minute presentations.…

Site Search

Company Search

Category: QualityStocksNewsBreaks